Danville, Pa.-based Gesinger will be the first system under the Risant umbrella, with Kaiser planning to add another five or so systems to the newly formed entity.
The move certainly caught several healthcare leaders off guard.
“We were all so focused on what will be the next healthcare move of Amazon, Microsoft and Google that we never saw Risant Health coming!” said Vikas Chowdhry, founder of TraumaCare.AI.
Geisinger Health, which will keep its name in the new deal, will enjoy a “turbo-boost,” according to its CEO Jaewon Ryu, MD, who will become Risant Health’s CEO.
The newly merged system would likely maintain the “AA-” credit ratings both Kaiser and Geisinger currently have, S&P Global said May 3.
Kaiser Permanente reported $233 million in operating income for the first quarter, reversing a $72 million loss in the same period in 2022.
The Risant Health transaction is subject to regulatory approval.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
